Latest Plasmodium Stories
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
A study conducted by researchers at the Johns Hopkins Malaria Research Institute and their Zambian colleagues detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia.
Researchers have revealed a new discovery in understanding how a malaria parasite invades human red blood cells.
Malaria is not only native to the New World, but it has been present long before humans existed and has evolved through birds and monkeys.
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease.
Malaria is a major global health concern, and researchers are in need of new therapeutic approaches.
Researchers at the University of South Florida (USF) College of Public College Health have shown for the first time in a rodent model that the earliest form of malaria parasites can lay dormant in red blood cells and “wake up,” or recover, following treatment with the antimalarial drug artesunate.
Researchers at the Perelman School of Medicine at the University of Pennsylvania, Monash University, and Virginia Tech have used a set of novel inhibitors to analyze how the malaria parasite, Plasmodium falciparum, uses enzymes to chew up human hemoglobin from host red blood cells as a food source.